The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 262.00
Bid: 262.60
Ask: 263.00
Change: 0.20 (0.08%)
Spread: 0.40 (0.152%)
Open: 262.20
High: 264.00
Low: 261.20
Prev. Close: 261.80
CTEC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Convatec Group PLC: Scrip Dividend - Calculation Price

17 Apr 2023 16:55

Convatec Group PLC (CTEC) Convatec Group PLC: Scrip Dividend - Calculation Price 17-Apr-2023 / 16:55 GMT/BST


Scrip Dividend – calculation price

 

Reading, United Kingdom (17 April 2023)

On 8 March 2023, the Board of Directors of Convatec Group Plc (“Convatec” or “the Company”) proposed a final dividend of 4.330 cents per share (“Final Dividend”), subject to approval at the forthcoming Annual General Meeting on 18 May 2023. This Final Dividend is to be paid on 25 May 2023 to shareholders on the share register as of 11 April 2023 (“Record Date”). The Final Dividend is payable in cash, in sterling to holders of ordinary shares. The chosen exchange rate for this payment is $1.184/£1.00, determined on 8 March 2023, giving a total sterling dividend of £74,744,400.80 A scrip dividend will be made available for this Final Dividend, allowing shareholders to elect to receive their dividend in the form of new ordinary shares.

The “Calculation Price” for the issue of new ordinary shares under the scrip dividend scheme is:

221.2 pence for each new ordinary share.

This is equivalent to 1 new share for approximately 60.49 shares held prior to the ex-dividend date of 6 April 2023.

The Calculation Price is the average of the middle market quotations of a Convatec share, derived from the London Stock Exchange Daily Official List, for the five consecutive business days from 6 April to 14 April 2023 (inclusive).

The latest date for receipt of elections to participate in the scrip dividend scheme for the Final Dividend is 3 May 2023. Shareholders must return their mandate form by 5pm (BST) or otherwise input their CREST elections to be received by the Company’s registrar, Computershare, by 3pm (BST). Elections received after this deadline will apply to subsequent dividends only. Unless revoked by a shareholder, a scrip dividend election will apply for all future dividends for which a scrip dividend is offered. Evergreen elections for CREST shareholders cannot be accepted and elections will revert to cash by default after the payment of each dividend.

Details of the scrip dividend scheme are available at www.convatecgroup.com/investors.

TIMETABLE

Key dates in respect of the scrip dividend scheme for the Final Dividend are:

Ex-dividend Date           6 April 2023

Record Date          11 April 2023

Scrip calculation price determined    6 April - 14 April 2023 (inclusive)

Scrip calculation price available and announced      17 April 2023

Mandate delivery deadline for Shares held in uncertificated form    3.00 p.m. on 3 May 2023

Mandate delivery deadline for Shares held in certificated form    5.00 p.m. on 3 May 2023 

Announcement of the total amount of new shares to be issued     9 May 2023

Dividend payment date         25 May 2023

Dispatch of statement in accordance with section 7 of Scheme     25 May 2023

Rules and share certificates, CREST accounts credited/updated

Enquiries 

 

Louise Bryson, Assistant Company Secretary   +44(0)7423 694919

 

Cosec@convatec.com 

 

Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92 

 

About Convatec  

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products

and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group revenues in 2022 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more about Convatec, please visit http://www.convatecgroup.com

 


Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
ISIN:GB00BD3VFW73
Category Code:DIV
TIDM:CTEC
LEI Code:213800LS272L4FIDOH92
Sequence No.:237436
EQS News ID:1609573
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
3rd Nov 20163:25 pmRNSNotification of major interest in shares
31st Oct 20162:45 pmRNSNotification of major interest in shares
31st Oct 20168:09 amRNSAdmission to Trading on the London Stock Exchange
26th Oct 20161:57 pmRNSPublication of a Prospectus
26th Oct 20167:00 amRNSOffer Price Announcement
26th Oct 20167:00 amRNSStabilisation Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.